Both in Pharmaceuticals
Atea Pharmaceuticals vs Emergent Biosolutions
Over the past year AVIR returned +28.3% and EBS returned −40.4%; their daily moves had a correlation of 0.15.
AVIR +28.3% EBS −40.4%Growth of $1, one year, split-adjusted
| Metric | AVIR | EBS |
|---|---|---|
| Price | $4.17 | $6.25 |
| Market cap | $334.5M | $320.5M |
| Today | +1.71% | −2.95% |
| 1 month | −18.7% | −13.7% |
| 6 months | −25.5% | −30.9% |
| Year to date | +16.8% | −49.4% |
| 1 year | +28.3% | −49.9% |
| Revenue growth (YoY) | — | +66.3% |
| Gross margin | — | 58.6% |
| Net margin | — | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $219.5M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.4% | 63.6% |
| Short % of float | 5.0% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).